Change of administration route of allergen immunotherapy: Rates and causes
Allergologia et Immunopathologia · 2025
DOI: 10.15586/aei.v53i2.1196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergologia et Immunopathologia, 2025. Verfasst von Cristina Rivas-Juesas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Paediatrics Department, Sagunto Hospital, Port de Sagunt, Valencia, Spain; crisrijue@gmail.com. Hauptthemen laut MEDLINE: Allergens, Desensitization, Immunologic, Hypersensitivity.
Abstract (Originalsprache)
Allergen immunotherapy (AIT) has shown efficacy in the short and the long term in the management of allergic respiratory diseases, and it’s administered subcutaneously (subcutaneous immunotherapy, or SCIT) or sublingually (sublingual immunotherapy, or SLIT), being both effective and safe options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Paediatrics Department, Sagunto Hospital, Port de Sagunt, Valencia, Spain; crisrijue@gmail.com.
- Paediatrics Department, Sagunto Hospital, Port de Sagunt, Valencia, Spain.
Zitieren
APA
Rivas-Juesas, C., & Vicente, A. D. (2025). Change of administration route of allergen immunotherapy: Rates and causes. Allergologia et Immunopathologia. https://doi.org/10.15586/aei.v53i2.1196
Vancouver
Rivas-Juesas C, Vicente AD. Change of administration route of allergen immunotherapy: Rates and causes. Allergologia et Immunopathologia. 2025. doi:10.15586/aei.v53i2.1196
BibTeX
@article{RivasJuesas2025,
author = {Rivas-Juesas, Cristina and Vicente, Ana Delgado},
title = {Change of administration route of allergen immunotherapy: Rates and causes},
journal = {Allergologia et Immunopathologia},
year = {2025},
doi = {10.15586/aei.v53i2.1196}
}
EUVIMED